TIS tissue therapies limited

prac report due today

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    Next step along the way to approval is today.

    The Pharmacovigilance Risk Assessment Committee rapporteur is due to submit the Risk Assessment Plan Assessment Report for Vitrogro today.

    To be perfectly honest I'm not entirely sure if this is a necessary step for devices or if it is only applicable to pharmaceuticals but I thought I'd inlcude it for the sake of completeness.

    Next update in one week, although I will be on leave and might forget.

    Rev
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.